Antimicrobial | Colistin-resistant group (n=51) | Colistin-susceptible group (n =100) | P-value | |
---|---|---|---|---|
No. (%) | No. (%) | |||
Amikacin | 45 (88.2) | 55 (55.0) | 0.000 | |
Ampicillin/sulbactam | 33 (64.7) | 51 (51.0) | 0.000 | |
Cefepime | 47 (92.2) | 60 (60.0) | 0.000 | |
Cefotaxime | 50 (98.0) | 60 (60.0) | 0.000 | |
Ceftazidime | 47 (92.2) | 60 (60.0) | 0.000 | |
Ciprofloxacin | 46 (90.2) | 58 (58.0) | 0.000 | |
Gentamicin | 46 (90.2) | 56 (56.0) | 0.000 | |
Imipenem | 51 (100.0) | 58 (58.0) | 0.000 | |
Meropenem | 48 (94.1) | 59 (59.0) | 0.000 | |
Minocycline | 23 (45.1) | 25 (25.0) | 0.004 | |
Piperacillin | 49 (96.1) | 62 (62.0) | 0.000 | |
Ticarcillin/Clavulanic | 48 (94.1) | 59 (59.0) | 0.000 | |
Trime thoprim/sulfamethoxazole | 44 (86.3) | 55 (55.0) | 0.000 |